Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics - Archive ouverte HAL Access content directly
Journal Articles Exploration of Targeted Anti-tumor Therapy Year : 2022

Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics

Abstract

During the past two decades, tremendous progress has been made in the dendrimer-based delivery of therapeutic molecules including, for instance, small molecules, macromolecules, and genes. This review deals with recent successes in the development of promising biocompatible phosphorus dendrimers, a specific type of dendrimer, to deliver genes to treat cancers.
Fichier principal
Vignette du fichier
Mignani, Engineered phosphorus dendrimers, 2022.pdf (1.88 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-03659099 , version 1 (04-05-2022)

Licence

Attribution

Identifiers

Cite

Serge Mignani, Xiangyang Shi, Maria Bryszewska, Dzmitry Shcharbin, Jean-Pierre Majoral. Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics. Exploration of Targeted Anti-tumor Therapy, 2022, 3 (1), pp.50-61. ⟨10.37349/etat.2022.00071⟩. ⟨hal-03659099⟩
37 View
27 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More